In This Issue
Page 1 to 3 of 3 |
Drug Discovery World Spring 2018 - Issue Summary Dr. Roger Brimblecombe
Several articles in recent additions of Drug Discovery World have pointed out that the chances of producing meaningful therapeutic advances in a timely and cost-effective manner are increased significantly if there are appropriate collaborations between organisations with complementary skills and experience.

Read More

Drug Discovery World Winter 2017/18 - Issue Summary Dr. Roger Brimblecombe
A recurrent theme in recent numbers of Drug Discovery World has been the increasing necessity for large companies to form relationships with smaller companies, contract research organisations and academia in the search for new leads to potential novel, safe and effective medicines and to expedite their development.

Read More

Drug Discovery World Fall 2017 - Issue Summary Dr Roger Brimblecombe
This issue of DDW, as always, carries a series of articles all of which reflect, in one way or another, the matters which are currently exercising the minds of those involved in drug discovery. For a considerable time now the most common theme by far has been the increasing price of drugs due largely to increased development costs which, in turn, are due in large part to the costs incurred by compounds which fail in the development process, especially in the later stages.

Read More

In This Issue
Page 1 to 3 of 3 |